Evidence map›Paper›PMID 29202038›Full record

ArticlemSphere

A Novel Biomimetic Nanosponge Protects the Retina from the

Austin L LaGrow, Phillip S Coburn, Frederick C Miller, Craig Land, Salai Madhumathi Parkunan, Brian T Luk, Weiwei Gao, Liangfang Zhang, Michelle C Callegan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Frontiers in cellular and infection microbiology · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The cereus matter of Bacillus endophthalmitis.Experimental eye research · 2020
    Review
  18. Frontiers in immunology · 2020
    Article
  19. Review
  20. Targets of immunomodulation in bacterial endophthalmitis.Progress in retinal and eye research · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Austin L LaGrowDepartment of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Phillip S CoburnDepartment of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Frederick C MillerDepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Craig LandDepartment of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Salai Madhumathi ParkunanDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Brian T LukDepartment of NanoEngineering and Moores Cancer Center, University of California San Diego, San Diego, California, USA.
Weiwei GaoDepartment of NanoEngineering and Moores Cancer Center, University of California San Diego, San Diego, California, USA.
Liangfang ZhangDepartment of NanoEngineering and Moores Cancer Center, University of California San Diego, San Diego, California, USA.
Michelle C CalleganDepartment of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
University of Oklahoma Health Sciences Center · USUniversity of California, San Diego · US

Funding

P30-CENTER CORE GRANT FOR VISION RESEARCHP30EY021725 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michelle C Callegan · 2011 to 2026
$10.5M
Vascular Permeability and Ocular InfectionsR01EY024140 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CALLEGAN, MICHELLE C · 2014 to 2017
$1.6M
Nanotherapeutics for Ocular InfectionsR01EY025947 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CALLEGAN, MICHELLE C, ZHANG, LIANGFANG · 2015 to 2017
$1.1M
NEI NIH HHS P30 EY021725NEI NIH HHS R01 EY024140NEI NIH HHS R01 EY025947
6 · The paper itself

Abstract

Intraocular infections are a potentially blinding complication of common ocular surgeries and traumatic eye injuries. Bacterial toxins synthesized in the eye can damage intraocular tissue, often resulting in poor visual outcomes.

Indexed as

cytolysincytotoxinsendophthalmitisEnterococcuseye infectionnanoparticlenanosponge

Identifiers

PMID29202038
PMCPMC5700372
OpenAlexW2769295426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.